These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7150440)

  • 1. [Official inspections of a pharmaceutical plant during the registration of new products].
    De Martiis F; Fontani F; Zanotti-Gerosa A
    Boll Chim Farm; 1982 Jul; 121(7):319-27. PubMed ID: 7150440
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Technicoscientific evolution and current direction of the standards regulating drug registration in Italy and in the European Economic Community].
    Battaglino G
    Boll Chim Farm; 1978 Jun; 117(6):313-24. PubMed ID: 743380
    [No Abstract]   [Full Text] [Related]  

  • 4. QUAD routes out inferior drugs.
    Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality assurance for medical products: unified program for all federal agencies.
    Flaherty FJ
    Hosp Formul; 1976 Dec; 11(12):669, 674, 679. PubMed ID: 1028796
    [No Abstract]   [Full Text] [Related]  

  • 6. [Various aspects of the significance of government control in drug supply].
    Teijgeler CA; Samsom RJ
    Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999
    [No Abstract]   [Full Text] [Related]  

  • 7. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some interpretations of controversial sub-sections in the Current Good Manufacturing Practice regulations for drug products.
    Loftus BT
    J Parenter Drug Assoc; 1979; 33(6):326-32. PubMed ID: 261583
    [No Abstract]   [Full Text] [Related]  

  • 9. World agencies try to stem flood of fake drugs.
    Surendran A
    Nat Med; 2004 Feb; 10(2):111. PubMed ID: 14760401
    [No Abstract]   [Full Text] [Related]  

  • 10. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technical-administrative aspects of the registration of pharmaceutical specialities].
    Marconi M; Battaglino G
    Boll Chim Farm; 1979 Mar; 118(3):118-34. PubMed ID: 475904
    [No Abstract]   [Full Text] [Related]  

  • 12. Registration of similar biological products--Singapore's approach.
    Poh J; Tam KT
    Biologicals; 2011 Sep; 39(5):343-5. PubMed ID: 21783381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug quality control work in Daru: observations during 1983-1986.
    Kibwage IO; Ogeto JO; Maitai CK; Rutere G; Thuranira J; Ochieng' A
    East Afr Med J; 1992 Oct; 69(10):577-80. PubMed ID: 1473513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Accession to the PIC/S and pharmaceutical quality system in Japan].
    Katori N
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):22-35. PubMed ID: 25707200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 16. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of globalization of drug manufacturing, production, and sourcing and challenges for American drug safety.
    Woo J; Wolfgang S; Batista H
    Clin Pharmacol Ther; 2008 Mar; 83(3):494-7. PubMed ID: 18253142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inspections: the international regulatory view.
    Turner JL
    PDA J Pharm Sci Technol; 1994; 48(4):180-1. PubMed ID: 7804815
    [No Abstract]   [Full Text] [Related]  

  • 19. Inspections: the international regulatory view--Japan.
    Kamura S
    PDA J Pharm Sci Technol; 1994; 48(4):182-3. PubMed ID: 7804816
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality assurance during the production process.
    Tucker JD
    Med Serv J Can; 1967 Mar; 23(3):262-9. PubMed ID: 6056371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.